Common Contracts
4 similar Investor Rights Agreement contracts by Armata Pharmaceuticals, Inc., Entasis Therapeutics Holdings Inc.
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • April 22nd, 2020 • Entasis Therapeutics Holdings Inc. • Pharmaceutical preparations • Delaware
This Investor Rights Agreement (this “Agreement”) is made and entered into as of April 22, 2020 by and between Entasis Therapeutics Holdings Inc., a Delaware corporation (the “Company”), and Innoviva, Inc., a Delaware corporation (the “Purchaser”), in connection with that certain Securities Purchase Agreement, dated as of April 12, 2020, by and between the Company and the Purchaser (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • April 13th, 2020 • Entasis Therapeutics Holdings Inc. • Pharmaceutical preparations • Delaware
This Investor Rights Agreement (this “Agreement”) is made and entered into as of April [●], 2020 by and between Entasis Therapeutics Holdings Inc., a Delaware corporation (the “Company”), and Innoviva, Inc., a Delaware corporation (the “Purchaser”), in connection with that certain Securities Purchase Agreement, dated as of April 12, 2020, by and between the Company and the Purchaser (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • February 13th, 2020 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Investor Rights Agreement (this “Agreement”) is made and entered into as of February 12, 2020 by and between Armata Pharmaceuticals Inc., a Washington corporation (the “Company”), and Innoviva, Inc., a Delaware corporation (the “Purchaser”), in connection with that certain Securities Purchase Agreement, dated as of January 27, 2020, by and between the Company and the Purchaser (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • January 29th, 2020 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Investor Rights Agreement (this “Agreement”) is made and entered into as of __________, 2020 by and between Armata Pharmaceuticals Inc., a Washington corporation (the “Company”), and Innoviva, Inc., a Delaware corporation (the “Purchaser”), in connection with that certain Securities Purchase Agreement, dated as of _________, 2020, by and between the Company and the Purchaser (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
